[去氨加压素：原发性夜间遗尿症的治疗]
[Desmopressin: the treatment of primary nocturnal enuresis].
作者信息
Granados E A, Garat J M
机构信息
Unidad de Urología Pediátrica, Fundación Puigvert, Barcelona, España.
出版信息
Arch Esp Urol. 1995 Apr;48(3):278-81.
OBJECTIVES
The efficacy of desmopressin, a drug that reduces nocturnal urine volume with no side effects, was evaluated in a group of 21 patients.
METHODS
20 boys and 1 girl with primary nocturnal enuresis were treated with intranasal desmopressin (DDAVP) for a period of 12 weeks.
RESULTS
An improvement in 80.95% was achieved. Following treatment enuresis recurred, but to a lesser degree than before therapy.
CONCLUSIONS
DDAVP is useful in the treatment of primary nocturnal enuresis whose etiology is not organic or functional.
目的
对21例患者使用去氨加压素（一种可减少夜间尿量且无副作用的药物）进行疗效评估。
方法
对20名男孩和1名患有原发性夜间遗尿症的女孩采用鼻内去氨加压素（DDAVP）治疗，为期12周。
结果
有效率达80.95%。治疗后遗尿复发，但程度较治疗前减轻。
结论
DDAVP对治疗病因非器质性或功能性的原发性夜间遗尿症有效。
Zotero 插件